IL185023A0 - Thiazolidinones for use as inhibitors of polo-like kinase (plk) - Google Patents
Thiazolidinones for use as inhibitors of polo-like kinase (plk)Info
- Publication number
- IL185023A0 IL185023A0 IL185023A IL18502307A IL185023A0 IL 185023 A0 IL185023 A0 IL 185023A0 IL 185023 A IL185023 A IL 185023A IL 18502307 A IL18502307 A IL 18502307A IL 185023 A0 IL185023 A0 IL 185023A0
- Authority
- IL
- Israel
- Prior art keywords
- thiazolidinones
- plk
- polo
- kinase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005005395A DE102005005395A1 (en) | 2005-02-03 | 2005-02-03 | New thiazolidinone compounds are polo-like kinase inhibitors, useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases, nephrological diseases and viral diseases |
US65123205P | 2005-02-10 | 2005-02-10 | |
PCT/EP2006/001037 WO2006082107A1 (en) | 2005-02-03 | 2006-02-02 | Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
Publications (1)
Publication Number | Publication Date |
---|---|
IL185023A0 true IL185023A0 (en) | 2007-12-03 |
Family
ID=38481436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL185023A IL185023A0 (en) | 2005-02-03 | 2007-08-02 | Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20070100830A (en) |
CR (1) | CR9323A (en) |
IL (1) | IL185023A0 (en) |
NO (1) | NO20074448L (en) |
-
2006
- 2006-02-02 KR KR1020077019939A patent/KR20070100830A/en not_active Application Discontinuation
-
2007
- 2007-08-02 IL IL185023A patent/IL185023A0/en unknown
- 2007-08-17 CR CR9323A patent/CR9323A/en not_active Application Discontinuation
- 2007-08-31 NO NO20074448A patent/NO20074448L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070100830A (en) | 2007-10-11 |
NO20074448L (en) | 2007-10-31 |
CR9323A (en) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1910348T3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
AP2470A (en) | Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase | |
TWI370127B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
ZA200806386B (en) | Thiazole compounds as protein kinase B (PKB) Inhibitors | |
HK1114380A1 (en) | Pyrrolopyrazoles as kinase inhibitors | |
ZA201002543B (en) | Polo-like kinase inhibitors | |
ZA200707520B (en) | Thiazolidnones for use as inhibitors of Polo-like kinase (Plk) | |
ZA200606683B (en) | Pyrazolotriazines as kinase inhibitors | |
EP1993539A4 (en) | Thiazolones for use as pi3 kinase inhibitors | |
EP2046333A4 (en) | Thiozolidinedione derivatives as p13 kinase inhibitors | |
EP1893607A4 (en) | Inhibitors of checkpoint kinases | |
IL190078A0 (en) | Kinase inhibitors | |
HK1134674A1 (en) | Sulfoximines as kinase inhibitors | |
PL1943243T3 (en) | Kinase inhibitors | |
EP1993535A4 (en) | Thiazolones for use as pi3 kinase inhibitors | |
IL194491A0 (en) | Thiazolyldihydroindazole derivatives as protein kinase inhibitors | |
EP1993536A4 (en) | Thiazolones for use as pi3 kinase inhibitors | |
EP1993537A4 (en) | Thiazolones for use as pi3 kinase inhibitors | |
EP1904449A4 (en) | Inhibitors of checkpoint kinases | |
EP1996191A4 (en) | Thiazolones for use as pi3 kinase inhibitors | |
EP1835918A4 (en) | Inhibitors of checkpoint kinases | |
EP1910365A4 (en) | Inhibitors of checkpoint kinases | |
IL185023A0 (en) | Thiazolidinones for use as inhibitors of polo-like kinase (plk) | |
ZA200710338B (en) | Oxydiazole derivatives as DGAT inhibitors | |
EP1993538A4 (en) | Thiazolones for use as pi3 kinase inhibitors |